Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisViral mutation ratesNew strategies against drug resistance to herpes simplex virusResistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsInhibitors of the Hepatitis C Virus Polymerase; Mode of Action and ResistanceHCV Kinetic Models and Their Implications in Drug DevelopmentHepatitis C virus molecular evolution: transmission, disease progression and antiviral therapyModelling hepatitis C therapy--predicting effects of treatmentLamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in PatientsExceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus InfectionMouse Systems to Model Hepatitis C Virus Treatment and Associated ResistanceA Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-EscapeMechanisms of viral mutationPotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsCell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirinElucidation of hepatitis C virus transmission and early diversification by single genome sequencingExtremely High Mutation Rate of HIV-1 In VivoConserved glycine 33 residue in flexible domain I of hepatitis C virus core protein is critical for virus infectivity.Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b.Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds.Mutational and fitness landscapes of an RNA virus revealed through population sequencingQuantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate.Rapid emergence of protease inhibitor resistance in hepatitis C virus.Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052A perspective on modelling hepatitis C virus infection.5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana.Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesisLethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir.Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients.The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment.Cell tropism predicts long-term nucleotide substitution rates of mammalian RNA viruses.Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1Role of ribavirin in HCV treatment response: now and in the future.Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2.Recombination in hepatitis C virus
P2860
Q21132564-0D1FD5E5-6411-4304-92E2-C05A281CEE81Q24611162-066813FA-107E-4EF1-A5F9-541F9AE368C1Q26749548-4BDB24A3-5749-41F6-8432-60B159D7A292Q26777408-912E8403-15C2-494E-8258-58C1429F5D1FQ26783056-29681BB5-EE0F-42EB-BB66-6D99DDCF8314Q26801602-7962CCDB-4C48-4363-839C-B96FB12D2D3BQ26853500-701F6932-9545-4CE6-9CC3-D3B6349D8647Q26864673-46CA34B1-3954-4D6B-BA8A-A9001F84509EQ27468616-8F73663F-75D9-4662-8C08-DE636D54A9F3Q27468696-CE4E391C-659D-4AD2-BB94-45BCDD952E5BQ27469038-8BA601DC-C46F-44C7-A10C-1D378F348EC1Q27664656-3A61CC47-C395-40D5-8860-44C0014AF876Q28067235-9ED87FF2-51AF-4004-A8D1-2BA690A5DCD6Q28471847-82D8FEBF-A3FE-48AA-A5ED-F1146A10AE10Q28474617-55ED9C51-3B99-4DDF-B0C5-304022F1921AQ28482493-BC20956D-706F-40D8-999D-73DA80A18585Q28548089-E6A8D745-5BF4-4833-B0A0-814BD74ADBAEQ30409246-7C1F974F-D16F-4FFE-BD98-2CBB4D1D8A30Q31149778-AF0040D4-72E8-47B6-94C5-7339079CAADCQ33741951-4E3E230F-5E09-4C19-8358-684465974129Q33953331-6E64C0CC-DC22-4479-9F7D-4EB931A32BE5Q34395271-183C103E-C2A7-4D45-84DD-1232CAB46B63Q34551913-7984F565-69AA-4D7C-84CE-2197934E9289Q34634791-DC0FE038-7AC6-4706-A63C-B142D12E1069Q34759489-A6A1E402-8382-4041-9EB6-D8BE2826E124Q35000909-3E0C61A7-5815-421F-B22D-8091BF861C90Q35579175-349C13F7-B708-4D4A-BCDB-6B00009AB804Q35873113-05D9BE0C-983D-482F-8961-6DFFC137F0B4Q36158234-BF4B4E1F-E962-4AFE-8A6C-128125704811Q36166222-1D13C2B5-F8B8-4168-8060-104EE57BE429Q36736898-1CD689F7-4470-4C08-9D89-C42FF53A2628Q36785846-4D97BFA1-57D1-4C94-9A62-6A33F0D110CDQ36810400-D6874156-CC72-4461-BA81-DA6C308C219AQ36827155-612955B9-0DDE-449E-A555-7AB444E39886Q37252631-A9A2BD3F-FADE-4399-A130-2E50CCFE1C79Q37458902-7E9E9E42-2744-4A56-9610-123BF310842DQ37547746-A7DC4269-A061-4315-B2F2-F03497E5F9E1Q37693948-36D6E812-7357-4D2B-ACEA-A69B37B04FB4Q37859393-76F06D04-68E1-4327-A331-737841EBB6A3Q37954260-557A626D-C00B-43B3-B4EB-F8CE02D4B613
P2860
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
description
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2009-06)
@fr
articolo scientifico (pubblicato il 2009-06)
@it
artigo científico (publicado na 2009-06)
@pt
artículu científicu espublizáu en 2009
@ast
im Juni 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 2009)
@en
vedecký článok (publikovaný 2009-06)
@sk
vetenskaplig artikel (publicerad på 2009-06)
@sv
name
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@ast
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@en
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@nl
type
label
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@ast
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@en
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@nl
prefLabel
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@ast
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@en
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@nl
P2860
P50
P3181
P356
P1433
P1476
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
@en
P2093
Rafael Sanjuán
P2860
P304
P3181
P356
10.1128/JVI.00201-09
P577
2009-06-01T00:00:00Z